Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: WWS who wrote (207)	1/23/1999 2:34:00 PM
From: Mike McFarland	Read Replies (4) \| Respond to of 613

Continued stem cell subthread--diabetes/CTII I saw a message regarding one of my other companies about being in the "quiet period". With their third quarter results having been sent October 30...would that put the company into the next so called quiet period? (As long as I'm here, another blurb from ctii PR, and then I'll let the thread take a breather from all this...) During the third quarter, the U.S. Patent Office has issued six new patents related to our proprietary encapsulated-cell technology that further strengthen our patent position in this important field. The recently issued patents broadly encompass methods of delivering biologically active molecules, methods of treating neurological disorders and methods for regulating cell growth within encapsulation devices. The Company's patent portfolio in the field of encapsulated-cell therapy now includes more than 50 issued or allowed U.S Patents covering methods of cell encapsulation, delivery of therapeutic molecules and treating disease, as well as other processes related to the surgical procedure, manufacture and transport of our implants. So I would guess that you encapsulate something in a very small membrane and embed the device in the pancreas in order to reestablish functionality. Ha...just displaying my ignorance on this! But maybe something like that... eom